Literature DB >> 19524574

Enrichment and clonal culture of progenitor cells during mouse postnatal liver development in mice.

Akihide Kamiya1, Sei Kakinuma, Yuji Yamazaki, Hiromitsu Nakauchi.   

Abstract

BACKGROUND & AIMS: Stem and progenitor cells exist in normal postnatal livers. However, it has not been possible to clonally isolate or analyze postnatal liver stem/progenitor-like cells (PLSCs) derived from noninjured livers because of a lack of specific surface markers. This study aimed to establish a primary culture system for clone-sorted PLSCs.
METHODS: To investigate proliferation and differentiation of PLSCs, subpopulations of nonparenchymal cells derived from noninjured livers were purified and cultured using a single-cell culture system. Cells were grown in fetal liver cell-derived conditioned medium in the presence of the Rho-associated kinase (ROCK) inhibitor Y-27632.
RESULTS: We identified CD13 and CD133 as markers expressed on the PLSC-containing population in noninjured livers and established an efficient single-cell culture system to clonally analyze PLSCs. Culture of PLSCs is difficult, even using conditioned medium, but the addition of Y-27632 increased PLSC cell proliferation. The proportion of progenitor cells among nonparenchymal cells decreased during postnatal liver development; however, a PLSC population was still preserved in 3-month-old mice. Long-term cultivated cells derived from clone-sorted cells in normal livers were established and were called normal-liver-derived stem-like cells (NLS cells). NLS cells could differentiate into hepatocyte-like and cholangiocyte-like cells under appropriate culture conditions and underwent self-renewal-like activity in serial reclone-sorted culture. CD13 and CD133 were expressed on progenitor cells derived from fetal and postnatal liver, whereas CD49f (integrin alpha6 subunit) was strongly expressed only on PLSCs.
CONCLUSIONS: These results demonstrate the presence of progenitor cells in the CD13(+)CD49f(+)CD133(+) subpopulation of nonhematopoietic cells derived from noninjured postnatal livers.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19524574     DOI: 10.1053/j.gastro.2009.06.001

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  37 in total

1.  Foxl1-Cre-marked adult hepatic progenitors have clonogenic and bilineage differentiation potential.

Authors:  Soona Shin; Gabriel Walton; Reina Aoki; Karrie Brondell; Jonathan Schug; Alan Fox; Olga Smirnova; Craig Dorrell; Laura Erker; Andrew S Chu; Rebecca G Wells; Markus Grompe; Linda E Greenbaum; Klaus H Kaestner
Journal:  Genes Dev       Date:  2011-06-01       Impact factor: 11.361

2.  Inhibition of notch signaling pathway prevents cholestatic liver fibrosis by decreasing the differentiation of hepatic progenitor cells into cholangiocytes.

Authors:  Xiao Zhang; Guangli Du; Ying Xu; Xuewei Li; Weiwei Fan; Jiamei Chen; Cheng Liu; Gaofeng Chen; Chenghai Liu; Mark A Zern; Yongping Mu; Ping Liu
Journal:  Lab Invest       Date:  2015-12-21       Impact factor: 5.662

Review 3.  Cellular homeostasis and repair in the mammalian liver.

Authors:  Ben Z Stanger
Journal:  Annu Rev Physiol       Date:  2015       Impact factor: 19.318

4.  Prospective isolation of a bipotential clonogenic liver progenitor cell in adult mice.

Authors:  Craig Dorrell; Laura Erker; Jonathan Schug; Janel L Kopp; Pamela S Canaday; Alan J Fox; Olga Smirnova; Andrew W Duncan; Milton J Finegold; Maike Sander; Klaus H Kaestner; Markus Grompe
Journal:  Genes Dev       Date:  2011-06-01       Impact factor: 11.361

5.  Model systems and clinical applications of hepatic stem cells for liver regeneration.

Authors:  Min Zhang; Yan Zhong; Jun Chen
Journal:  Hepatol Int       Date:  2011-12-21       Impact factor: 6.047

Review 6.  The origin, biology, and therapeutic potential of facultative adult hepatic progenitor cells.

Authors:  Soona Shin; Klaus H Kaestner
Journal:  Curr Top Dev Biol       Date:  2014       Impact factor: 4.897

7.  Identification of a candidate stem cell in human gallbladder.

Authors:  Rohan Manohar; Yaming Li; Helene Fohrer; Lynda Guzik; Donna Beer Stolz; Uma R Chandran; William A LaFramboise; Eric Lagasse
Journal:  Stem Cell Res       Date:  2015-02-07       Impact factor: 2.020

8.  Lineage fate of ductular reactions in liver injury and carcinogenesis.

Authors:  Simone Jörs; Petia Jeliazkova; Marc Ringelhan; Julian Thalhammer; Stephanie Dürl; Jorge Ferrer; Maike Sander; Mathias Heikenwalder; Roland M Schmid; Jens T Siveke; Fabian Geisler
Journal:  J Clin Invest       Date:  2015-04-27       Impact factor: 14.808

9.  Stem cell-based therapies for liver diseases: state of the art and new perspectives.

Authors:  Anna Chiara Piscaglia; Mariachiara Campanale; Antonio Gasbarrini; Giovanni Gasbarrini
Journal:  Stem Cells Int       Date:  2010-09-01       Impact factor: 5.443

Review 10.  The potential role of liver stem cells in initiation of primary liver cancer.

Authors:  Xiao-Song Zhi; Jun Xiong; Xiao-Yuan Zi; Yi-Ping Hu
Journal:  Hepatol Int       Date:  2016-05-02       Impact factor: 6.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.